Insider Transactions in Q1 2026 at Terns Pharmaceuticals, Inc. (TERN)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2026
|
Amy L. Burroughs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,339
-33.92%
|
$2,710,882
$38.1 P/Share
|
|
Jan 05
2026
|
Amy L. Burroughs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+41.63%
|
-
|
|
Jan 02
2026
|
Emil Kuriakose Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,155
-1.12%
|
$43,890
$38.98 P/Share
|
|
Jan 02
2026
|
Amy L. Burroughs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,551
+26.32%
|
$86,204
$4.64 P/Share
|